CosmosID, provider of leading products and services to unlock the microbiome accurately and actionably, is proud to announce that Dr. Arne Materna is joining its Senior Leadership team as Vice President of Product. Dr. Materna’s […]
Prevalence of Chronic Kidney Illness in India is 17.2% and rising (Singh AK, Farag YM, Mittal BV, et al. Epidemiology and risk factors of chronic kidney disease in India– results from the SEEK (Screening and […]
MyBiotics Pharma Ltd., a microbiome therapeutics company, announced today that it has entered into a second option agreement with Ferring Holding Ltd. for the validation of MyBiotics’ microbiome-based therapeutics in the field of women’s health. […]
Prairie-grown potatoes have been enjoyed across Canada for years, and now through a patented technology a Manitoba company is transforming the popular tubers into an all-natural, single ingredient prebiotic fibre supplement that leads to improved […]
Second Genome, Inc., a leader in the development of novel medicines derived from the human microbiome, today announced the initiation of four collaborations with key academic institutions to evaluate the effect of gut microbiota on […]
Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, today provided a clinical programs update and reported financial results for […]
Metagenics, Inc., a health sciences company, has joined the UC San Diego Center for Microbiome Innovation (CMI) as an industry sponsor. CMI encompasses a large range of expertise from microbiome sampling, a broad range of […]
NESS ZIONA, Israel, Jan. 30, 2018 /PRNewswire/ — BiomX Ltd., a microbiome company developing customized phage therapies, today announced that it has exclusively sub-licensed from JSR Corporation a set of bacterial targets for the development and […]